United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Aura Biosciences raises $80m for VDC therapies for cancers Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round… bySrinathMarch 22, 2021
